Assay designed to measure toxicity in mammalian cells and cell lines in culture
For efficient transfection of cell lines, e.g. HepG2, HL-60, Jurkat, K-562 , MCF7, SH-SY5Y, or THP-1, in the NucleofectorTM I/II/2b System
Do you need a quote right away? Add this product to your shopping cart, go to your cart and click on “Generate Quote”. Your quote will be available straight away to view, save online, and download in PDF format.
Cryopreserved ampule of Normal Human Knee Articular Chondrocytes (NHAC-kn) containing ≥ 750,000 cells
Human CD8+/CD45RA+ naïve cytotoxic T cells, isolated from peripheral blood using negative immunomagnetic selection, ≥ 5 million cells, cryopreserved
Complete cell culture kit containing a cryopreserved ampule of mammary epithelial cells (catalog no. CC-2551) and MEGMTM BulletKitTM Mammary Epithelial Cell Growth Media (catalog no. CC-3150) for culture of Mammary Epithelial Cells.
Annual WinKQCLTM Software Support for P/N 25-501
-
Application ExampleAnalysis of undirected migration of NK cells
-
Undirected Migration Assay of NK Cells -
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
NK-92 Transfection Protocol - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of NK-92 cells with the Cell Line Nucleofector™ Kit R
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay -
Predicting Antibody Dependent Cell-Mediated Cytotoxicity (ADCC)Genotypic and Phenotypic Screening of Human Peripheral Blood Mononuclear Cells
-
Genome Editing using Nucleofector® Technology – Citation ListSelected citations for genome editing using ZFN, TALEN or CRISPR/Cas9 or transposition systems (e.g. for CAR-T) in combination with Lonza's Nucleofector® Technology.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)